S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AXSM Axsome Therapeutics Inc

122.10

-2.31 (-1.86%)

08 Mar 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics Inc News

Form 8-K - Current report
Wednesday 5 March 2025 (5 days ago) • Edgar (US Regulatory)

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA
Wednesday 5 March 2025 (5 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 3 March 2025 (7 days ago) • Edgar (US Regulatory)

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission
Monday 3 March 2025 (7 days ago) • GlobeNewswire Inc.

Axsome Therapeutics to Participate in Upcoming Investor Conferences
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors
Monday 24 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Tuesday 18 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

More Axsome Therapeutics Inc News Articles

Jyske Bank AS (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions